Evaluation of HEArt invoLvement in Patients With FABRY Disease
Recruiting · NCT03362164 · Observational (researchers observe without assigning treatment) · Lead sponsor: Wuerzburg University Hospital
View the official record on ClinicalTrials.gov →What this trial is about
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Fabry disease (genetically confirmed)
- Signed informed consent
- 18 years and older
Exclusion criteria
- No informed consent
- Withdrawal of informed consent
Where it is running
2 locations listed.
- Wuerzburg University Hospital - Würzburg, Bavaria, Germany
- Wuerzburg University Hospital - Würzburg, Bavaria, Germany